Farmacosmo S.p.A. (BIT:COSMO)

Farmacosmo Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.12	5.07	6.85	1.41	2.06
Cash & Short-Term Investments	3.12	5.07	6.85	1.41	2.06
Cash Growth	-38.37%	-26.06%	385.48%	-31.44%	118.40%
Accounts Receivable	3.7	4.95	5.26	4.81	4.26
Other Receivables	1.07	1.86	4.88	0.87	0.28
Receivables	4.77	6.82	10.14	5.68	4.54
Inventory	9.26	7.33	4.73	2.08	0.98
Prepaid Expenses	-	-	0.17	-	-
Other Current Assets	-0	-	-	-	-
Total Current Assets	17.95	19.96	21.89	9.17	7.58
Property, Plant & Equipment	0.29	0.49	0.48	0.3	0.19
Long-Term Investments	0.05	0.05	0.05	0.06	0.02
Goodwill	8.28	10.85	11.18	0	0
Other Intangible Assets	2.93	2.87	2.32	0.59	0.5
Long-Term Accounts Receivable	-	-	0.05	-	-
Long-Term Deferred Charges	1.19	1.95	2.78	0.51	0.31
Other Long-Term Assets	0.18	0.23	0.47	0.14	0.1
Total Assets	30.87	36.4	39.24	10.77	8.71
Accounts Payable	10.24	11.91	14.5	8.01	7.24
Accrued Expenses	0.34	0.2	0.16	0.03	0.04
Current Portion of Long-Term Debt	6.65	5.19	0.69	0.24	0.1
Current Income Taxes Payable	0.38	0.32	0.41	0.39	0.41
Other Current Liabilities	0.73	0.78	2.19	0.16	0.09
Total Current Liabilities	18.34	18.41	17.96	8.83	7.88
Long-Term Debt	0.68	1.5	1.18	0.38	-
Long-Term Unearned Revenue	0.24	0.38	0.53	0.18	0.11
Long-Term Deferred Tax Liabilities	0.01	0.03	0.03	-	-
Other Long-Term Liabilities	0.77	0.7	0.54	0.42	0.17
Total Liabilities	20.03	21.03	20.22	9.8	8.15
Common Stock	3.48	3.48	3.01	0.07	0.07
Additional Paid-In Capital	13.79	13.79	14.26	-	-
Retained Earnings	-6.58	-4.25	0.38	0.9	0.49
Treasury Stock	-0.11	-0.11	-0.25	-	-
Comprehensive Income & Other	-0	-0	-	-	-
Total Common Equity	10.58	12.91	17.4	0.97	0.55
Minority Interest	0.25	2.46	1.62	-	-
Shareholders' Equity	10.84	15.37	19.02	0.97	0.55
Total Liabilities & Equity	30.87	36.4	39.24	10.77	8.71
Total Debt	7.33	6.69	1.87	0.62	0.1
Net Cash (Debt)	-4.21	-1.63	4.98	0.79	1.95
Net Cash Growth	-	-	530.10%	-59.56%	108.47%
Net Cash Per Share	-0.11	-0.04	-	0.03	-
Filing Date Shares Outstanding	38.81	38.81	-	30	-
Total Common Shares Outstanding	38.81	38.81	-	30	-
Working Capital	-0.39	1.55	3.94	0.35	-0.3
Book Value Per Share	0.27	0.33	-	0.03	-
Tangible Book Value	-0.62	-0.81	3.89	0.38	0.05
Tangible Book Value Per Share	-0.02	-0.02	-	0.01	-
Land	0.14	0.14	-	0.14	0.07
Machinery	0.43	0.56	-	0.28	0.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.